Market Watch:
LifeVantage Corporation announced today that Aspenwood Capital has completed a $3.5 million private placement for the Company to accredited investors.
Aspenwood Capital partner Steve Ossello said, “As active investment bankers for LifeVantage over the past several years, we have always been tremendous supporters of the company and its primary product – Protandim(R). This capital raising effort is particularly gratifying now that the company’s exciting new network marketing strategy should provide Protandim(R) with the distribution it richly deserves.”
LifeVantage CEO and President David Brown said, “We are extremely pleased with the success of this raise. This vote of confidence from investors is an excellent reflection on the direction of the Company and the many exciting developments that have recently occurred. The proceeds from this financing should allow the Company to accomplish several goals, including the expansion of our infrastructure and marketing efforts for our network marketing program.”
Logo from LifeVantage